{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:58:52Z","timestamp":1791939532257,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T00:00:00Z","timestamp":1569369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5P30AR057230"],"award-info":[{"award-number":["5P30AR057230"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-15-1-0182"],"award-info":[{"award-number":["W81XWH-15-1-0182"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["CIRM TRX-05426"],"award-info":[{"award-number":["CIRM TRX-05426"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007185","name":"University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008574","name":"Center for Duchenne Muscular Dystrophy, University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008574","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.omtn.2019.09.020","type":"journal-article","created":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T01:46:23Z","timestamp":1569635183000},"page":"580-589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Targeting RyR Activity Boosts Antisense Exon 44 and 45 Skipping in Human DMD Skeletal or Cardiac Muscle Culture Models"],"prefix":"10.1016","volume":"18","author":[{"given":"Florian","family":"Barth\u00e9l\u00e9my","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie D.","family":"Douine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene E.","family":"Marcantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley F.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Carrie","family":"Miceli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2019.09.020_bib1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2019.09.020_bib2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/360591a0","article-title":"Primary structure of dystrophin-related protein","volume":"360","author":"Tinsley","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2019.09.020_bib3","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/nm.3990","article-title":"Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division","volume":"21","author":"Dumont","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2019.09.020_bib4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.stem.2019.01.002","article-title":"EGFR-Aurka Signaling Rescues Polarity and Regeneration Defects in Dystrophin-Deficient Muscle Stem Cells by Increasing Asymmetric Divisions","volume":"24","author":"Wang","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtn.2019.09.020_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.omtn.2019.09.020_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/humu.22758","article-title":"The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations","volume":"36","author":"Bladen","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2019.09.020_bib7","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/mt.2010.186","article-title":"In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse","volume":"18","author":"Aoki","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2019.09.020_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1073\/pnas.0406700102","article-title":"Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles","volume":"102","author":"Lu","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2019.09.020_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1073\/pnas.98.1.42","article-title":"Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse","volume":"98","author":"Mann","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2019.09.020_bib10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.nmd.2006.05.017","article-title":"Induced dystrophin exon skipping in human muscle explants","volume":"16","author":"McClorey","year":"2006","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtn.2019.09.020_bib11","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/sj.gt.3302800","article-title":"Antisense oligonucleotide-induced exon skipping restores dystrophin expression in\u00a0vitro in a canine model of DMD","volume":"13","author":"McClorey","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2019.09.020_bib12","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/hmg\/10.15.1547","article-title":"Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells","volume":"10","author":"van Deutekom","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2019.09.020_bib13","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/sj.mt.6300095","article-title":"Antisense oligonucleotide-induced exon skipping across the human dystrophin gene transcript","volume":"15","author":"Wilton","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2019.09.020_bib14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.21627","article-title":"Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs","volume":"65","author":"Yokota","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2019.09.020_bib15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/oli.2005.15.284","article-title":"Functional analysis of 114 exon-internal AONs for targeted DMD exon skipping: indication for steric hindrance of SR protein binding sites","volume":"15","author":"Aartsma-Rus","year":"2005","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.omtn.2019.09.020_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/nat.2017.0682","article-title":"Development of Exon Skipping Therapies for Duchenne Muscular Dystrophy: A Critical Review and a Perspective on the Outstanding Issues","volume":"27","author":"Aartsma-Rus","year":"2017","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtn.2019.09.020_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/nat.2016.0657","article-title":"FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga","volume":"27","author":"Aartsma-Rus","year":"2017","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtn.2019.09.020_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ana.24555","article-title":"Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy","volume":"79","author":"Mendell","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2019.09.020_bib19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2044.2004.03658.x","article-title":"Dantrolene--a review of its pharmacology, therapeutic use and new developments","volume":"59","author":"Krause","year":"2004","journal-title":"Anaesthesia"},{"key":"10.1016\/j.omtn.2019.09.020_bib20","doi-asserted-by":"crossref","first-page":"164ra160","DOI":"10.1126\/scitranslmed.3005054","article-title":"Dantrolene enhances antisense-mediated exon skipping in human and mouse models of Duchenne muscular dystrophy","volume":"4","author":"Kendall","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2019.09.020_bib21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.omtn.2018.02.002","article-title":"Repurposing Dantrolene for Long-Term Combination Therapy to Potentiate Antisense-Mediated DMD Exon Skipping in the mdx Mouse","volume":"11","author":"Wang","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2019.09.020_bib22","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/humu.23561","article-title":"DMD genotype correlations from the Duchenne Registry: Endogenous exon skipping is a factor in prolonged ambulation for individuals with a defined mutation subtype","volume":"39","author":"Wang","year":"2018","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2019.09.020_bib23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.stem.2016.01.021","article-title":"A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells","volume":"18","author":"Young","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtn.2019.09.020_bib24","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1096\/fj.201700182RRR","article-title":"Ryanodine channel complex stabilizer compound S48168\/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy","volume":"32","author":"Capogrosso","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.omtn.2019.09.020_bib25","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.nmd.2018.06.009","article-title":"Personalized gene and cell therapy for Duchenne Muscular Dystrophy","volume":"28","author":"Barth\u00e9l\u00e9my","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtn.2019.09.020_bib26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3233\/JND-180357","article-title":"Report of a TREAT-NMD\/World Duchenne Organisation Meeting on Dystrophin Quantification Methodology","volume":"6","author":"Aartsma-Rus","year":"2019","journal-title":"J.\u00a0Neuromuscul. Dis."},{"key":"10.1016\/j.omtn.2019.09.020_bib27","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.omtn.2018.09.017","article-title":"NS-065\/NCNP-01: An Antisense Oligonucleotide for Potential Treatment of Exon 53 Skipping in Duchenne Muscular Dystrophy","volume":"13","author":"Watanabe","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2019.09.020_bib28","doi-asserted-by":"crossref","first-page":"10981","DOI":"10.1038\/ncomms10981","article-title":"Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice","volume":"7","author":"Han","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2019.09.020_bib29","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/mt.2009.320","article-title":"Guanine analogues enhance antisense oligonucleotide-induced exon skipping in dystrophin gene in\u00a0vitro and in\u00a0vivo","volume":"18","author":"Hu","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2019.09.020_bib30","doi-asserted-by":"crossref","first-page":"10488","DOI":"10.1038\/ncomms10488","article-title":"The lack of the Celf2a splicing factor converts a Duchenne genotype into a Becker phenotype","volume":"7","author":"Martone","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2019.09.020_bib31","doi-asserted-by":"crossref","first-page":"e8348","DOI":"10.1371\/journal.pone.0008348","article-title":"Identification of small molecule and genetic modulators of AON-induced dystrophin exon skipping by high-throughput screening","volume":"4","author":"O\u2019Leary","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2019.09.020_bib32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/mus.880140603","article-title":"Effect of dantrolene in Duchenne muscular dystrophy","volume":"14","author":"Bertorini","year":"1991","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtn.2019.09.020_bib33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nm.1916","article-title":"Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle","volume":"15","author":"Bellinger","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2019.09.020_bib34","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1073\/pnas.0711074105","article-title":"Remodeling of ryanodine receptor complex causes \u201cleaky\u201d channels: a molecular mechanism for decreased exercise capacity","volume":"105","author":"Bellinger","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2019.09.020_bib35","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1101\/gad.1837009","article-title":"An inducible change in Fox-1\/A2BP1 splicing modulates the alternative splicing of downstream neuronal target exons","volume":"23","author":"Lee","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtn.2019.09.020_bib36","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1371\/journal.pbio.0050040","article-title":"Depolarization and CaM kinase IV modulate NMDA receptor splicing through two essential RNA elements","volume":"5","author":"Lee","year":"2007","journal-title":"PLoS Biol."},{"key":"10.1016\/j.omtn.2019.09.020_bib37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1055\/s-2002-33031","article-title":"Respiratory complications of the muscular dystrophies","volume":"23","author":"Simonds","year":"2002","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.omtn.2019.09.020_bib38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm1345","article-title":"Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology","volume":"12","author":"Alter","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2019.09.020_bib39","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1038\/mt.2008.207","article-title":"A single intravenous injection of adeno-associated virus serotype-9 leads to whole body skeletal muscle transduction in dogs","volume":"16","author":"Yue","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2019.09.020_bib40","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.bbamem.2010.02.012","article-title":"Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy","volume":"1798","author":"Moulton","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtn.2019.09.020_bib41","doi-asserted-by":"crossref","first-page":"13810","DOI":"10.1074\/jbc.M006104200","article-title":"Dantrolene inhibition of ryanodine receptor Ca2+ release channels. Molecular mechanism and isoform selectivity","volume":"276","author":"Zhao","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2019.09.020_bib42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1124\/mol.115.097691","article-title":"Essential Role of Calmodulin in RyR Inhibition by Dantrolene","volume":"88","author":"Oo","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.omtn.2019.09.020_bib43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-1-4939-8651-4_19","article-title":"Validation and Detection of Exon Skipping Boosters in DMD Patient Cell Models and mdx Mouse","volume":"1828","author":"Barthelemy","year":"2018","journal-title":"Methods Mol. Biol."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253119302677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253119302677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:42:06Z","timestamp":1784652126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253119302677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":43,"alternative-id":["S2162253119302677"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2019.09.020","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting RyR Activity Boosts Antisense Exon 44 and 45 Skipping in Human DMD Skeletal or Cardiac Muscle Culture Models","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2019.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s).","name":"copyright","label":"Copyright"}]}}